No Data
No Data
Express News | Reported Friday, BioAffinity Technologies Names Back J. Michael Edwards As Interim CFO Following Michael Dougherty's Resignation
BioAffinity Technologies: Financial Chief Michael Dougherty to Resign Sept. 15
Express News | BioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
Maxim Group Maintains BioAffinity Technologies(BIAF.US) With Buy Rating, Maintains Target Price $6
BioAffinity Technologies GAAP EPS of -$0.19, Revenue of $2.4M
10-Q: Q2 2024 Earnings Report
No Data